The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
Open accessAbstract
Next-generation sequencing (NGS) technology has expanded in the last decades with significant improvements in the reliability, sequencing chemistry, pipeline analyses, data interpretation and costs. Such advances make the use of NGS feasible in clinical practice today. This review describes the recent technological developments in NGS applied to the field of oncology. A number of clinical applications are reviewed, i.e., mutation detection in inherited cancer syndromes based on DNA-sequencing, detection of spliceogenic variants based on RNA-sequencing, DNA-sequencing to identify risk modifiers and application for pre-implantation genetic diagnosis, cancer somatic mutation analysis, pharmacogenetics and liquid biopsy. Conclusive remarks, clinical limitations, implications and ethical considerations that relate to the different applications are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–279 of 279
The Evolution of Cancer Risk Assessment in the Era of Next Generation Sequencing
Fecteau, H., Vogel, K. J., Hanson, K., & Morrill‐Cornelius, S. M. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9714-7 · Cited by 75
Apellániz-Ruiz, M., Lee, M., Sánchez, L. M. M., Gutiérrez‐Gutiérrez, G., Calvo, I., García‐Estévez, L., Sereno, M., García-Donás, J., Castelo, B., Guerra, E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1758 · Cited by 75
Mannan, A. U., Singh, J., Lakshmikeshava, R., Thota, N., Singh, S., Sowmya, T., Mishra, A., Sinha, A. P., Deshwal, S., Soni, M. R., et al. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.4 · Cited by 75
Turning of COGS moves forward findings for hormonally mediated cancers
Sakoda, L. C., Jorgenson, E., & Witte, J. S. (2013) · Nature Genetics · doi:10.1038/ng.2587 · Cited by 72
The Cancer Genome Atlas Research Network: A Sight to Behold
Giordano, T. J. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9345-4 · Cited by 72
ESHRE Task Force on Ethics and Law22: Preimplantation Genetic Diagnosis
de Wert, G. M. W. R., Dondorp, W., Shenfield, F., Devroey, P., Tarlatzis, B. C., Barri, P. N., Diedrich, K., Provoost, V., & Pennings, G. (2014) · Human Reproduction · doi:10.1093/humrep/deu132 · Cited by 71
Tinhofer, I., Budach, V., Saki, M. R., Konschak, R., Niehr, F., Jöhrens, K., Weichert, W., Linge, A., Lohaus, F., Krause, M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.01.003 · Cited by 70
Kriegsmann, M., Endris, V., Wolf, T. A., Pfarr, N., Stenzinger, A., Loibl, S., Denkert, C., Schneeweiß, A., Budczies, J., Sinn, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2481 · Cited by 69
Шао, Д., Lin, Y., Liu, J., Wan, L., Zu, L., Cheng, S., Fei, L., Deng, R., Wang, J. Z., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep22338 · Cited by 69
Li, Z., Guo, X., Wu, Y., Li, S., Yan, J., Peng, L., Xiao, Z. Q., Wang, S., Deng, Z., Dai, L., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3276-8 · Cited by 68
Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions
Ballester, L. Y., Sarabia, S. F., Sayeed, H., Patel, N. R., Baalwa, J., Athanassaki, I. D., Hernandez, J. A., Fang, E., Quintanilla, N., Roy, A., et al. (2015) · Pediatric and Developmental Pathology · doi:10.2350/15-05-1638-oa.1 · Cited by 68
Next-Generation Sequencing for Inherited Breast Cancer Risk: Counseling through the Complexity
Rainville, I. R., & Rana, H. Q. (2014) · Current Oncology Reports · doi:10.1007/s11912-013-0371-z · Cited by 66
Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer Medicine
Damodaran, S., Berger, M. F., & Roychowdhury, S. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e175 · Cited by 64
Snape, K. M. G., Ruark, E., Tarpey, P. S., Renwick, A., Turnbull, C., Seal, S., Murray, A., Hanks, S., Douglas, J. B., Stratton, M. R., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2057-x · Cited by 63
Bourgon, R., Lu, S., Yan, Y., Lackner, M. R., Wang, W., Weigman, V., Wang, D., Guan, Y., Ryner, L. C., Koeppen, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3114 · Cited by 61
Schenkel, L. C., Kerkhof, J., Stuart, A., Reilly, J., Eng, B., Woodside, C., Levstik, A., Howlett, C. J., Rupar, C. A., Knoll, J. H. M., et al. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.04.002 · Cited by 60
Fassan, M., Simbolo, M., Bria, E., Mafficini, A., Pilotto, S., Capelli, P., Bencivenga, M., Pecori, S., Luchini, C., Neves, D., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0315-1 · Cited by 59
Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data
Cimino, P. J., Zhao, G., Wang, D., Sehn, J. K., Lewis, J. S., & Duncavage, E. J. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.03.010 · Cited by 55
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
Patel, J. N. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s62918 · Cited by 55
Hoppman‐Chaney, N. L., Peterson, L. M., Klee, E. W., Middha, S., Courteau, L. K., & Ferber, M. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.145441 · Cited by 53
Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors
Kurihara, S., Ueda, Y., Onitake, Y., Sueda, T., Ohta, E., Morihara, N., Hirano, S., Irisuna, F., & Hiyama, E. (2015) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.08.033 · Cited by 52
Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer
Lerner‐Ellis, J. P., Khalouei, S., Sopik, V., & Narod, S. A. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1090879 · Cited by 52
Preimplantation diagnosis for neurofibromatosis
Verlinsky, Y., Rechitsky, S., Verlinsky, O., et al. (2002) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61809-3 · Cited by 52
Wong, S. Q., FELLOWES, A. P., Doig, K. M., Ellul, J., Bosma, T. J., Irwin, D. E., Vedururu, R., Tan, A., Weiss, J. M., Chan, K. S., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.80 · Cited by 52
Comparison of genome sequencing and clinical genotyping for pharmacogenes
Yang, W., Wu, G., Broeckel, U., Smith, C., Turner, V., Haidar, C. E., Wang, S., Carter, R., Karol, S. E., Neale, G. A. M., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.411 · Cited by 52
HBOC multi-gene panel testing: comparison of two sequencing centers
Schroeder, C., Faust, U., Sturm, M., Hackmann, K., Grundmann, K., Harmuth, F., Bosse, K., Kehrer, M., Benkert, T., Klink, B., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3429-9 · Cited by 51
Use of panel tests in place of single gene tests in the cancer genetics clinic
Yorczyk, A., Robinson, L. S., & Ross, T. S. (2014) · Clinical Genetics · doi:10.1111/cge.12488 · Cited by 51
Detection of novel germline mutations for breast cancer in non‐ BRCA 1/2 families
Aloraifi, F., McDevitt, T., Martiniano, R., McGreevy, J., McLaughlin, R. L., Egan, C. M., Cody, N., Meany, M., Kenny, E. M., Green, A., et al. (2015) · FEBS Journal · doi:10.1111/febs.13352 · Cited by 51
Clinical next generation sequencing to identify actionable aberrations in a phase I program
Boland, G. M., Piha-Paul, S. A., Subbiah, V., Routbort, M. J., Herbrich, S. M., Baggerly, K., Patel, K. P., Brusco, L., Horombe, C., Naing, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4040 · Cited by 49
Zhang, L., Chen, L., Sah, S., Latham, G. J., Patel, R., Song, Q., Koeppen, H., Tam, R., Schleifman, E., Mashhedi, H., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0180 · Cited by 49
Li-Chang, H. H., Kasaian, K., Ng, Y., Lum, A. M., Kong, E., Lim, H. J., Jones, S. J. M., Huntsman, D. D., Schaeffer, D. F., & Yip, S. S. F. (2015) · BMC Cancer · doi:10.1186/s12885-015-1021-7 · Cited by 48
Frey, M. K., Kim, S. H., Bassett, R. Y., Martineau, J., Dalton, E., Chern, J., & Blank, S. V. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.08.006 · Cited by 47
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Ku, B. M., Jung, H. A., Sun, J., Ko, Y. H., Jeong, H., Son, Y., Baek, C., Park, K., & Ahn, M. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0299-6 · Cited by 47
Li, N., Wang, L., Wang, H., Ma, M., Wang, X., Li, Y., Zhang, W., Zhang, J., Cram, D. S., & Yao, Y. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.03.001 · Cited by 45
Lih, C., Sims, D. J., Harrington, R. D., Polley, E. C., Zhao, Y., Mehaffey, M. G., Forbes, T. D., Das, B., Walsh, W. D., Datta, V., et al. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.07.006 · Cited by 45
Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma
Zhou, J., Huang, A., & Yang, X. (2016) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9801-0 · Cited by 43
Molecular Inversion Probes for targeted resequencing in non-model organisms
Niedzicka, M., Fijarczyk, A., Dudek, K., Stuglik, M., & Babik, W. (2016) · Scientific Reports · doi:10.1038/srep24051 · Cited by 43
Genetic profiles of cervical tumors by high‐throughput sequencing for personalized medical care
Müller, E., Brault, B., Holmes, A. M., Legros, A., Jeannot, E., Campitelli, M., Rousselin, A., Goardon, N., Frébourg, T., Krieger, S., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.492 · Cited by 42
Preusser, M., Berghoff, A. S., Koller, R., Zielinski, C. C., Hainfellner, J. A., Liebmann‐Reindl, S., Popitsch, N. P., Geier, C. B., Streubel, B., & Birner, P. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.107 · Cited by 42
Gleeson, F. C., Kipp, B. R., Voss, J. S., Campion, M. B., Minot, D. M., Tu, Z. J., Klee, E. W., Sciallis, A. P., Graham, R. P., Lazaridis, K. N., et al. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpu3j7fgayqbrl · Cited by 42
Unclassified variants identified in BRCA1 exon 11: Consequences on splicing
Anczuków, O., Buisson, M., Salles, M., Triboulet, S., Longy, M., Lidereau, R., Sinilnikova, O. M., & Mazoyer, S. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20546 · Cited by 41
Tockner, B., Köcher, T., Hainzl, S., Reichelt, J., Bauer, J. W., Koller, U., & Murauer, E. M. (2016) · Gene Therapy · doi:10.1038/gt.2016.57 · Cited by 41
Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study
Caux‐Moncoutier, V., Pagès-Berhouet, S., Michaux, D., Asselain, B. J. R., Castéra, L., Pauw, A. D., Buecher, B., Gauthier‐Villars, M., Stoppa‐Lyonnet, D., & Houdayer, C. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.89 · Cited by 40
Campos, B., Dı́ez, O., Domènech, M., Baena, M., Balmañà, J., Sanz, J., Ramírez, A., Alonso, C., & Baiget, M. (2003) · Human Mutation · doi:10.1002/humu.9176 · Cited by 39
Kim, S., Lee, J., Hong, M. E., Do, I., Kang, S. Y., Ha, S. Y., Kim, S. T., Park, S. H., Kang, W. K., Choi, M. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111693 · Cited by 38
Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing
Brandão, R. D., van Roozendaal, K. E. P., Tserpelis, D., Gómez-García, E. B., & Blok, M. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1599-7 · Cited by 37
Self-citationTammiste, A., Jiang, T., Fischer, K., Mägi, R., Krjutškov, K., Pettai, K., Esko, T., Li, Y., Tansey, K. E., Carroll, L., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113499829 · Cited by 36
Colapietro, P., Gervasini, C., Natacci, F., Rossi, L. M. G., Riva, P., & Larizza, L. (2003) · Human Genetics · doi:10.1007/s00439-003-1009-2 · Cited by 36
Rutter, J. L., Goldstein, A. M., Dávila, M. R., Tucker, M. A., & Struewing, J. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206564 · Cited by 34
Genomics of Cancer and a New Era for Cancer Prevention
Brennan, P., & Wild, C. P. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005522 · Cited by 34
Ananda, G., Mockus, S. M., Lundquist, M., Spotlow, V., Simons, A., Mitchell, T. N., Stafford, G. A., Philip, V. M., Stearns, T. M., Srivastava, A., et al. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.12.009 · Cited by 32
Kim, S. T., Lee, J., Hong, M. E., Park, K., Park, J. O., Ahn, T. J., Park, Y. S., Park, Y. S., Lim, H. Y., Ahn, J. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5188 · Cited by 32
Somatic DNA mutation analysis in targeted therapy of solid tumours.
Yu, B., O'Toole, S. A., & Trent, R. J. (2015) · PubMed · doi:10.3978/j.issn.2224-4336.2015.04.04 · Cited by 32
Chevrier, S., Arnould, L., Ghiringhelli, F., Coudert, B. P., Fumoleau, P., & Boidot, R. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2528 · Cited by 31
Common genetic variants and cancer risk in Mendelian cancer syndromes
Antoniou, A. C., & Chenevix‐Trench, G. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.010 · Cited by 31
Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma
Huang, J., Löhr, M. J., NILSSON, M. H. L., Segersvärd, R., Matsson, H., Verbeke, C. S., Heuchel, R. L., Kere, J., Iafrate, A. J., Zheng, Z., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238543 · Cited by 28
Pinto, P., Paulo, P., Santos, C., Rocha, P., Pinto, C., Veiga, I., Pinheiro, M., Peixoto, A., & Teixeira, M. R. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3948-z · Cited by 28
Karageorgos, I. L., Mizzi, C., Giannopoulou, E., Pavlidis, C., Peters, B. A., Zagoriti, Z., Stenson, P. D., Mitropoulos, K. A., Borg, J., Kalofonos, H. P., et al. (2015) · Human Genomics · doi:10.1186/s40246-015-0034-2 · Cited by 27
Cheng, D. T., Cheng, J., Mitchell, T. N., Syed, A., Zehir, A., Mensah, N. Y. T., Oultache, A., Nafa, K., Levine, R. L., Arcila, M. E., et al. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.05.006 · Cited by 26
Gleeson, F. C., Kipp, B. R., Kerr, S. E., Voss, J. S., Lazaridis, K. N., Katzka, D. A., & Levy, M. J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.017 · Cited by 25
Hilbers, F., Meijers, C. M., Laros, J. F. J., van Galen, M., Hoogerbrugge, N., Vasen, H. F. A., Nederlof, P. M., Wijnen, J., van Asperen, C. J., & Devilee, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055734 · Cited by 25
Sie, A. S., Prins, J. B., van Zelst–Stams, W. A. G., Veltman, J. A., Feenstra, I., & Hoogerbrugge, N. (2014) · Clinical Genetics · doi:10.1111/cge.12433 · Cited by 25
Fonseca, I., Bell, A., Wani, K., & Bell, D. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22238 · Cited by 23
Genetic Mutation Analysis of Human Gastric Adenocarcinomas Using Ion Torrent Sequencing Platform
Xu, Z., Huo, X., Ye, H., Tang, C., Nandakumar, V., Lou, F., Zhang, D., Dong, H., Sun, H., Jiang, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100442 · Cited by 23
Fiorentino, M., Gruppioni, E., Massari, F., Giunchi, F., Altimari, A., Ciccarese, C., Bimbatti, D., Scarpa, A., Iacovelli, R., Porta, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12551 · Cited by 23
Park, D. J., Odefrey, F., Hammet, F., Giles, G. G., Baglietto, L., Abcfs, MCCS, Hopper, J. L., Schmidt, D. F., Makalic, E., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1704-y · Cited by 21
Platt, J., Cox, R., & Enns, G. M. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-013-9683-2 · Cited by 20
Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study
Tabone, T., Abuhusain, H. J., Nowak, A. K., Erber, W. N., & McDonald, K. L. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202173 · Cited by 20
Altarescu, G., Zeevi, D. A., Zeligson, S., Perlberg, S., Eldar‐Geva, T., Margalioth, E. J., Levy‐Lahad, E., & Renbaum, P. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0044-8 · Cited by 19
Virk, S. M., Gibson, R. M., Quiñones‐Mateu, M. E., & Barnholtz‐Sloan, J. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124178 · Cited by 17
Mutalib, N. A., Syafruddin, S. E., Zain, R. R. M., Dali, A. Z. H. M., Yunos, R. I. M., Saidin, S., Jamal, R., & Mokhtar, N. M. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-805 · Cited by 17
Advances in Hereditary Colorectal and Pancreatic Cancers
Underhill-Blazey, M. L., Germansky, K. A., & Yurgelun, M. B. B. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.017 · Cited by 17
Germline RAD51B truncating mutation in a family with cutaneous melanoma
Wadt, K., Aoude, L. G., Golmard, L., Hansen, T. V. O., Sastre‐Garau, X., Hayward, N. K., & Gerdes, A. (2015) · Familial Cancer · doi:10.1007/s10689-015-9781-4 · Cited by 16
Boleij, A., Initiative, D. R. E., Tops, B. B. J., Rombout, P. D. M., Dequeker, E. M., Ligtenberg, M. J. L., & van Krieken, J. H. (2015) · Oncotarget · doi:10.18632/oncotarget.3804 · Cited by 15
Development of a Center for Personalized Cancer Care at a Regional Cancer Center
Lane, B. R., Bissonnette, J., Waldherr, T. L., Ritz‐Holland, D., Chesla, D. W., Cottingham, S. L., Alberta, S., Liu, C., Thompson, A. B., Graveel, C. R., et al. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.07.003 · Cited by 15
Kotoula, V., Lyberopoulou, A., Papadopoulou, K., Charalambous, E., Alexopoulou, Z., Gakou, C., Lakis, S., Tsolaki, E., Λιλάκος, Κ., & Fountzilas, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128818 · Cited by 13
Burghel, G. J., Hurst, C. D., Watson, C. M., Chambers, P. A., Dickinson, H., Roberts, P., & Knowles, M. A. (2015) · BioMed Research International · doi:10.1155/2015/478017 · Cited by 13
Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia
Haslam, K., Catherwood, M. A., Dobbin, E., Sproul, A. M., Langabeer, S. E., & Mills, K. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0222-3 · Cited by 10
Jóri, B., Kamps, R., Xanthoulea, S., Delvoux, B., Blok, M. J., de Vijver, K. K. V., de Koning, B., Oei, F. T., Tops, C. M. J., Speel, E. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5694 · Cited by 9
Self-citation
Cited by
Artificial intelligence in healthcare
Yu, K.-H., Beam, A. L., & Kohane, I. S. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0305-z · Cited by 2,817
Next-Generation Sequencing Technology: Current Trends and Advancements
Satam, H., Joshi, K., Mangrolia, U., Waghoo, S., Zaidi, G., Rawool, S., Thakare, R. P., Banday, S., Mishra, A. K., Das, G., et al. (2023) · Biology · doi:10.3390/biology12070997 · Cited by 1,299
“NGS has facilitated the identification and characterization of these extended sets of genes associated with HBOC, expanding our knowledge of hereditary cancer predisposition [197].”
BackgroundProstate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
A deep learning model to predict RNA-Seq expression of tumours from whole-slide images
Schmauch, B., Romagnoni, A., Pronier, E., Saillard, C., Maillé, P., Calderaro, J., Kamoun, A., Sefta, M., Toldo, S., Zaslavskiy, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17678-4 · Cited by 533
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
Retracted
Metadata
- Authors
- Kamps, R., Brandão, R., Bosch, B., Paulussen, A., Xanthoulea, S., Blok, M., & Romano, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-01-31
- Volume
- 18
- Issue
- 2
- Pages
- 308
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2585769337
- Cited by
- 453
- References
- 279
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.